BALDELLI, SARA
BALDELLI, SARA
Universita' degli Studi di MILANO
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects
2022 C. Carnovale, C. Perrotta, S. Baldelli, D. Cattaneo, C. Montrasio, S. S Barbieri, G. Pompilio, C. Vantaggiato, E.G.I. Clementi, M. Pozzi
In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5
2021 S. Cheli, M. Fusi, A. De Silvestri, I. Bonini, E. Clementi, D. Cattaneo, C. Montrasio, S. Baldelli
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samples
2021 S. Baldelli, M. Cerea, D. Mangioni, L. Alagna, A. Muscatello, A. Bandera, D. Cattaneo
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens
2021 D. Cattaneo, M. Fusi, V. Micheli, C. Resnati, P. Meraviglia, M.V. Cossu, S. Vimercati, G.C. Bisinella, S. Baldelli, S. Antinori, C. Gervasoni
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment
2021 S. Cheli, S. Baldelli, A. De Silvestri, M. Fusi, D. Minisci, C. Gervasoni, D. Cattaneo, E. Clementi, P. Meraviglia, C. Montrasio
Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: A Narrative Review
2020 D. Cattaneo, S. Baldelli, V. Cozzi, E. Clementi, D.J. Marriott, C. Gervasoni
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action?
2020 D. Cattaneo, M. Fusi, V. Cozzi, S. Baldelli, I. Bonini, C. Gervasoni, E. Clementi
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
2019 S. Corti, P. Pileri, M.I. Mazzocco, C. Mando', A.F. Moscatiello, D. Cattaneo, S. Cheli, S. Baldelli, P. Laura, E.G.I. Clementi, I. Cetin
Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis
2019 S. Baldelli, M. Fusi, V. Cozzi, E. Clementi, N.M.L. Faelli, M. Russo, C. Colombo, D. Cattaneo
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial
2018 E. Colella, D. Cattaneo, L. Galli, S. Baldelli, E. Clementi, M. Galli, A. Lazzarin, A. Castagna, S. Rusconi, V. Spagnuolo
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid
2018 S. Castoldi, V. Cozzi, S. Baldelli, S. Fucile, E. Clementi, D. Cattaneo
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF
2018 D. Cattaneo, D. Minisci, S. Baldelli, C. Mazzali, A. Giacomelli, L. Milazzo, P. Meraviglia, C. Resnati, G. Rizzardini, E. Clementi, M. Galli, C. Gervasoni
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions
2018 C. Rafaniello, M. Sessa, F.F. Bernardi, M. Pozzi, S. Cheli, D. Cattaneo, S. Baldelli, M. Molteni, R. Bernardini, F. Rossi, E. Clementi, C. Bravaccio, S. Radice, A. Capuano
Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study
2017 C. Rovera, M.C. Mauri, C. Di Pace, S. Paletta, A. Reggiori, V. Ciappolino, D. Cattaneo, S. Baldelli, E. Clementi, A.C. Altamura
Quetiapine-Induced Hypomania and its Association with Quetiapine/Norquetiapine Plasma Concentrations : A Case Series of Bipolar Type 2 Patients
2017 C. Rovera, C. Esposito, V. Ciappolino, D. Cattaneo, S. Baldelli, E.G.I. Clementi, A.C. Altamura, M. Buoli
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma
2017 S. Baldelli, G. Marrubini, D. Cattaneo, E. Clementi, M. Cerea
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics?
2017 S. Baldelli, E. Clementi, D. Cattaneo
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma
2016 S. Baldelli, D. Cattaneo, P. Pignatelli, V. Perrone, D. Pastori, S. Radice, F. Violi, E. Clementi
Determinants of bone diseases in tenofovir-treated HIV patients
2016 C. Gervasoni, D. Minisci, P. Meraviglia, S. Baldelli, E. Clementi, G. Rizzardini, D. Cattaneo
Identification of different patterns of dabigatran in vivo bioactivation in patients on maintenance anticoagulation therapy
2016 S. Baldelli, D. Cattaneo, M. Cerea, P. Pignatelli, F. Violi, E. Clementi